Page 1 | Search Results | Archives of Pathology & Laboratory Medicine

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Pan-Cancer Biomarkers: Changing the Landscape of Molecular Testing

Jinjuan Yao, MD, PhD, Maria E. Arcila, MD, Marc Ladanyi, MD, PhD, Jaclyn F. Hechtman, MD

Arch Pathol Lab Med (2020) 145 (6): 692–698.

https://doi.org/10.5858/arpa.2020-0513-RA

Published: 29 December 2020

View article titled, Pan-Cancer Biomarkers: Changing the Landscape of Molecular Testing

Journal Articles

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Neal I. Lindeman, MD, Philip T. Cagle, MD, Dara L. Aisner, MD, PhD, Maria E. Arcila, MD, Mary Beth Beasley, MD ...

Arch Pathol Lab Med (2018) 142 (3): 321–346.

https://doi.org/10.5858/arpa.2017-0388-CP

Published: 22 January 2018

View article titled, Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Includes: Supplementary data

Journal Articles

Optimizing Workflows and Processing of Cytologic Samples for Comprehensive Analysis by Next-Generation Sequencing: Memorial Sloan Kettering Cancer Center Experience

Shaozhou Ken Tian, MD, J. Keith Killian, MD, PhD, Natasha Rekhtman, MD, PhD, Ryma Benayed, PhD, Sumit Middha, PhD ...

Arch Pathol Lab Med (2016) 140 (11): 1200–1205.

https://doi.org/10.5858/arpa.2016-0108-RA

Published: 02 September 2016

View article titled, Optimizing Workflows and Processing of Cytologic Samples for Comprehensive Analysis by Next-Generation Sequencing: Memorial Sloan Kettering Cancer Center Experience

Journal Articles

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Neal I. Lindeman, MD, Philip T. Cagle, MD, Mary Beth Beasley, MD, Dhananjay Arun Chitale, MD, Sanja Dacic, MD, PhD ...

Arch Pathol Lab Med (2013) 137 (6): 828–860.

https://doi.org/10.5858/arpa.2012-0720-OA

Published: 03 April 2013

View article titled, Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Includes: Supplementary data

Journal Articles

Morphologic Features of Adenocarcinoma of the Lung Predictive of Response to the Epidermal Growth Factor Receptor Kinase Inhibitors Erlotinib and Gefitinib

Maureen F. Zakowski, MD, Sanaa Hussain, MD, William Pao, MD, PhD, Marc Ladanyi, MD, Michelle S. Ginsberg, MD ...

Arch Pathol Lab Med (2009) 133 (3): 470–477.

https://doi.org/10.5858/133.3.470

Published: 01 March 2009

View article titled, Morphologic Features of Adenocarcinoma of the Lung Predictive of Response to the Epidermal Growth Factor Receptor Kinase Inhibitors Erlotinib and Gefitinib

NARROW

Pan-Cancer Biomarkers: Changing the Landscape of Molecular Testing

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Optimizing Workflows and Processing of Cytologic Samples for Comprehensive Analysis by Next-Generation Sequencing: Memorial Sloan Kettering Cancer Center Experience

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Morphologic Features of Adenocarcinoma of the Lung Predictive of Response to the Epidermal Growth Factor Receptor Kinase Inhibitors Erlotinib and Gefitinib

Get Email Alerts

Pan-Cancer Biomarkers: Changing the Landscape of Molecular Testing

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Optimizing Workflows and Processing of Cytologic Samples for Comprehensive Analysis by Next-Generation Sequencing: Memorial Sloan Kettering Cancer Center Experience

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Morphologic Features of Adenocarcinoma of the Lung Predictive of Response to the Epidermal Growth Factor Receptor Kinase Inhibitors Erlotinib and Gefitinib

Get Email Alerts

This Feature Is Available To Subscribers Only